"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

G1 Therapeutics get $33M for Cancer Treatment

About a year after it raised $12.5 million, it announced Thursday that it raised another $33 million, including from Eshelman Ventures, the investment fund founded byFred Eshelman, one of the most successful people in the Triangle pharmaceutical space.

Valeant buys Salix for $10 billion

Raleigh-based Salix Pharmaceuticals was officially acquired by Valeant Pharmaceuticals International for $158 per share, or about $10 billion in cash.

We’ll be back in Charleston!

Please join us in beautiful Charleston, S.C. next November for the 17th Annual SEBIO Investor & Partnering Forum!

More details to come in early 2015